| 发明名称 |
N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-[1,3,4-OXADIAZOL-2-YL]PHENYL)PYRIDINE-3-SULPHONAMIDE FOR THE TREATMENT OF CANCER |
| 摘要 |
THE USE OF N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-( 4-[1 ,3,4-OXADIAZOL-2YL]PHENYL)PYRIDINE-3-SULPHONAMIDE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN THE TREATMENT OF CANCER AND/OR PAIN IN A WARM BLOODED ANIMAL SUCH AS MAN IS DESCRIBED.
|
| 申请公布号 |
MY136449(A) |
申请公布日期 |
2008.10.31 |
| 申请号 |
MYPI20033175 |
申请日期 |
2003.08.21 |
| 申请人 |
ASTRAZENECA AB |
发明人 |
DAVID WILLIAM TONGE;SIAN TOMIKO TAYLOR;FRANCIS THOMAS BOYLE;ANDREW MARK HUGHES;DONNA JOHNSTONE;MARIANNE BERNICE ASHFORD;NIGEL CHARLES BARRASS |
| 分类号 |
C07D413/14;A61K31/497;A61P9/00;A61P25/02;A61P25/04;A61P29/00;A61P35/00;A61P35/02;A61P35/04;A61P43/00 |
主分类号 |
C07D413/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
